000			01446nam a2200325Ia 4500
001			0000071734
005			20171002053550.0
006			m u
007			cr cn|||||||||
008			980107s1997 dcua sb 000 0 eng d
010			_z 98119250
020			_z0309059763
035			_a(CaPaEBR)ebr10055149
035			_a(OCoLC)43477344
040			_aCaPaEBR _cCaPaEBR
050	1	4	_aRM666.T784 _bI56 1997eb
082	0	4	_a615/.782 _221
110	2		_aInstitute of Medicine (U.S.). _bCommittee on Halcion: An Assessment of Data Adequacy and Confidence.
245	1	0	_aHalcion _h[electronic resource] : _ban independent assessment of safety and efficacy data / _cCommittee on Halcion: An Assessment of Data Adequacy and Confidence, Division of Health Sciences Policy, Division of Neuroscience and Behavioral Health, Institute of Medicine.
260			_aWashington, D.C. : _bNational Academy Press, _c1997.
300			_axviii, 158 p. : _btables.
504			_aIncludes bibliographical references.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2009. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
650		0	_aTriazolam.
650		0	_aTranquilizing drugs.
655		7	_aElectronic books. _2local
710	2		_aebrary, Inc.
856	4	0	_uhttp://site.ebrary.com/lib/daystar/Doc?id=10055149 _zAn electronic book accessible through the World Wide Web; click to view
908			_a170314
942	0	0	_cEB
999			_c60892 _d60892